2018•PubMedRequires access

Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder.

Nancy H. Goodbar, Katherine Hanlon

Abstract

Implantable buprenorphine is an expensive alternative for patients on a stable dosage of transmucosal buprenorphine. Based on current research and guidance, implantable buprenorphine should not be used as initial treatment for opioid dependence or as a substitute for medication-assisted treatments other than transmucosal buprenorphine.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Buprenorphine, Medicine, Opioid use disorder, Opioid, Anesthesia, Intensive care medicine, Internal medicine, Receptor